Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome editing of PAR2 through targeted delivery of CRISPR-Cas9 system for alleviating acute lung inflammation via ERK/NLRP3/IL-1β and NO/iNOS signalling

18 Aug 2023

Abstract excerpt

Excessive and uncontrollable inflammatory responses in alveoli can dramatically exacerbate pulmonary disease progressions through vigorous cytokine releases, immune cell infiltration and protease-driven tissue damages. It is an urgent need to explore potential drug strategies for mitigating lung inflammation. Protease-activated receptor 2 (PAR2) as a vital molecular target principally participates in various...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Extracellular vesicles in disease
Share to Phagocytosis and Immune Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38487002
DOI: 10.1016/j.apsb.2023.08.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome editing of PAR2 through targeted delivery of CRISPR-Cas9 system for alleviating acute lung inflammation via ERK/NLRP3/IL-1β and NO/iNOS signallingPMID 38487002Read ↗

Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney CellsSemantic proximity Read ↗

Protease-Activated Receptors in the Intestine: Focus on Inflammation and CancerSemantic proximity Read ↗

CRISPR interference-mediated silencing of pro-inflammatory genes in autoimmune models: functional and biophysical evaluation with sustained effects in primary human PBMCsSemantic proximity Read ↗

Gene editing as a promising approach for respiratory diseases.Semantic proximity Read ↗

Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease <i>Ctsl</i>Semantic proximity Read ↗

Serpin peptidase inhibitor, clade E, member 2 in physiology and pathology: recent advancementsSemantic proximity Read ↗

Physiology and Pathophysiology of Proteinase-Activated Receptors (PARs): PAR-2 as a Potential Therapeutic TargetSemantic proximity Read ↗

PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skinSemantic proximity Read ↗

Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages.Semantic proximity Read ↗

Peptidylarginine Deiminase 2 in Host Immunity: Current Insights and PerspectivesSemantic proximity Read ↗

Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling.Semantic proximity Read ↗

Inflammasome Modulation Enhances the Immunoregulatory Function of Mesenchymal Stromal Cells under Bacterial and Titanium-induced InflammationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.